N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function. - Wikidata - awgldk - TriplyDB

N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function.

N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function.

http://www.wikidata.org/entity/Q34594978

about

Structural insights on the role of antibodies in HIV-1 vaccine and therapy HIV-1 neutralizing antibodies: understanding nature's pathways Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies Progress in HIV-1 vaccine development.Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1 Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies.Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth Glycan-Dependent Neutralizing Antibodies Are Frequently Elicited in Individuals Chronically Infected with HIV-1 Clade B or C.Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV.Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding.Germline-targeting immunogens.Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV.Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity.Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.

P2860

Q26829461-9ECD9860-2507-45B8-B5CB-234359E88D25 Q27000480-214260BE-69B6-4325-838A-19B8ED5D0AEE Q27644634-15926FFA-B75D-4B94-9BDB-02CDDFD2DDD8 Q27677570-D2A17FE4-7F2B-47F9-9920-84612C282FEB Q27680499-B34706AB-5E71-4C44-B96A-F407C5FA9493 Q27680688-36D624EF-B896-4FDD-9006-5ADB9A5E4C07 Q27693849-326E28A9-96CF-4965-BE4F-B4C56BD55E36 Q30353580-A078117D-F4B1-4A01-A6A9-ACBCDCB3F7A9 Q34991017-4FAFA211-2BFB-44F9-B334-8D8A951091D5 Q35817106-24FAA925-1258-4309-B785-09EDFDA572A7 Q36194234-BF20E475-A293-4A9A-B000-3DF17F3CE0D0 Q36294701-5571244B-4091-4A4B-AFC5-526BA1D320C5 Q37242530-8AF20E5E-110C-4998-8DEB-682BF68A63D8 Q37415418-2EA66B39-41E6-4060-944B-345D2004699C Q38764547-6AD99491-B28C-4C31-8B0F-54E358956C93 Q40290521-C5DB5EE8-8968-4F11-8430-8DCD4D2EDFB9 Q42215329-AB47E47B-21F9-42AC-A99A-E77FC3AD8D34 Q46226616-ED3F2A55-C167-44C3-A4F1-3C61EF375046 Q55003064-7BF05737-6D98-40D0-97B2-9D3AB3E358A8

P2860

N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function.

http://www.wikidata.org/entity/Q34594978

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

N332-Directed broadly neutrali ...... n complementation of function.

@ast

N332-Directed broadly neutrali ...... n complementation of function.

@en

N332-Directed broadly neutrali ...... n complementation of function.

@nl

type

label

N332-Directed broadly neutrali ...... n complementation of function.

@ast

N332-Directed broadly neutrali ...... n complementation of function.

@en

N332-Directed broadly neutrali ...... n complementation of function.

@nl

prefLabel

N332-Directed broadly neutrali ...... n complementation of function.

@ast

N332-Directed broadly neutrali ...... n complementation of function.

@en

N332-Directed broadly neutrali ...... n complementation of function.

@nl

P1433

Q34594978-F4CB1809-9B51-4884-8D56-7B5B6FCAA2B3

P1476

Q34594978-4F4210D2-A577-42B0-8C49-34D2B9DF7FF0

P2093

Q34594978-166917D1-D527-4AF3-BE7D-9CC5C62CCAAD

Q34594978-2B37826E-10F8-42D7-982F-A21734DB4975

Q34594978-46A4F95D-C4E7-4120-A371-65ED249DACD6

Q34594978-6223FD82-B767-40DA-AF4D-E7CABF1BE343

Q34594978-6302B572-0C17-4DFE-B957-DD6BBBEDCC66

Q34594978-720EF3CA-AF33-4206-8C65-C141E473C149

Q34594978-8C301424-A2CF-4809-B4C6-D1291951EEA4

Q34594978-9EDB90CB-4B68-4662-8DF3-5AC62B4AB6AE

Q34594978-DCC098E4-618D-4ADD-8C36-9A3AC00786D0

Q34594978-EBB87FBD-4CBE-4634-891F-5020BC64B3DA

P2860

Q34594978-02CA2061-8F70-4F4A-A974-9E34CC154E52

Q34594978-04A0EFDB-C2A6-4442-9DCA-78C45B86CD25

Q34594978-08DD31D1-B4ED-4A09-80BF-2A09D5F32886

Q34594978-0AE8EA47-E969-4317-B962-559F347092B9

Q34594978-0CF0EB9D-11DF-4850-A0D0-3DAD576ECAC2

Q34594978-15E40DD4-2EB4-495F-A923-323006598A0E

Q34594978-175C6D79-87AA-42F5-BFA2-1D6A6A3E17E4

Q34594978-1A88F7F6-F972-4062-AB50-9182B50CB430

Q34594978-209AE24D-71A2-4737-AED1-2C1613FED0D4

Q34594978-24277B71-20C2-4D6A-A7D5-98D5488B2826

P304

Q34594978-2835167E-4C6A-4A72-839E-67A0E6DDFCAA

P31

Q34594978-7C44D4DC-60E4-45E0-8CF1-D80D32459F32

P356

Q34594978-34E61A7A-D0EB-4DAB-9833-37C5CFE378B8

P407

Q34594978-81B4207F-5FE9-4965-BDF8-CC36B73D3972

P433

Q34594978-85AD8171-BAB7-444F-9FCB-8EB5AD383F46

P478

Q34594978-09CAF459-C592-4EDE-BBA1-990F4D153B3C

P50

Q34594978-42B2C45B-D7D2-4A6F-845D-437B38B0C7AE

Q34594978-B636FACE-9FCA-44FD-B77B-02B1A424AC42

P577

Q34594978-53148429-2051-493C-9FEA-B5BF71D6D26A

P5875

Q34594978-08D00035-432F-4E87-9F89-806CDA7790DA

P698

Q34594978-A3C159F2-96FE-4DC5-9BBD-2768F604A2D3

P921

Q34594978-07D81115-A1DD-4E6D-B51C-282E115E4BA9

P932

Q34594978-06146B57-501B-480D-AC61-54FA1996F259

P356

JOURNAL.PONE.0055701

P1433

P1476

N332-Directed broadly neutrali ...... n complementation of function.

@en

P2093

Dennis R Burton

http://www.w3.org/2001/XMLSchema#string

Gabriel Lu

http://www.w3.org/2001/XMLSchema#string

Jason S McLellan

http://www.w3.org/2001/XMLSchema#string

Jiang Zhu

http://www.w3.org/2001/XMLSchema#string

Jonathan Stuckey

http://www.w3.org/2001/XMLSchema#string

Marie Pancera

http://www.w3.org/2001/XMLSchema#string

Mark K Louder

http://www.w3.org/2001/XMLSchema#string

Peter D Kwong

http://www.w3.org/2001/XMLSchema#string

Wayne C Koff

http://www.w3.org/2001/XMLSchema#string

Yongping Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple sequence alignment with the Clustal series of programs

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120

Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

Clustal W and Clustal X version 2.0

Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies

P304

e55701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0055701

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235691906

http://www.w3.org/2001/XMLSchema#string

P698

23431362

http://www.w3.org/2001/XMLSchema#string

P921

P932

3576407

http://www.w3.org/2001/XMLSchema#string